ALLR News and Press, Allarity Therapeutics Inc. From 04/04/24

2024-04-04 09:28:02 ET More on Allarity Therapeutics Seeking Alpha’s Quant Rating on Allarity Therapeutics Read the full article on Seeking Alpha For further details see: Allarity Therapeutics to implement 1-for-20 reverse stock split

Boston (April 4, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the implementation of a reverse stock split of it...

The stenoparib Phase 2 monotherapy trial in advanced, recurrent ovarian cancer continues to show promise, prompting shift in resources to accelerate stenoparib development Further development of IXEMPRA ® and dovitinib is de-prioritized The Company has been ab...

Boston (March 25, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that the Company has been granted a formal exten...

2024-03-08 08:44:33 ET More on Allarity Therapeutics Allarity Therapeutics appoints co-founder Thomas Jensen as interim CEO Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial information f...

Leadership Changes Led by Appointment of Co-Founder Thomas Jensen as Interim CEO and Jeremy Graff, Ph.D., former Eli Lilly Executive, as Executive Advisor Reduced Net Loss from Operations by 50% and Reduced Net Loss by 26% Announced Data in December 2023 from Advanced Ovar...

Genesco Inc. (GCO) is expected to report $2.66 for Q4 2024 Broadway Financial Corporation (BYFC) is expected to report for quarter end 2023-12-31 Oji Holdings Corporation ADR (OJIPY) is expected to report for Q3 2024 Hibbett Inc. (HIBB) is expected to report $2.54 for Q4 2024 GRI ...

Boston (February 28, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, is pleased to announce that it has been invited to present at...

2024-01-08 14:54:36 ET More on Markets Cathie Wood: Probability is very high that a Spot Bitcoin ETF will be approved this week Market returns are broadening out from the Magnificent 7 - Principal Financial Group Real Estate is the top performing sector since the mar...

2023-12-12 06:09:27 ET More on Allarity Therapeutics Allarity stock soars 60% premarket on ovarian cancer therapy results Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial information for...